| Formation Metals Advances 2025 Drilling Program with ATI Application for N2 Property |
VANCOUVER, BC / ACCESS Newswire / May 16, 2025 / Formation Metals Inc. ("Formation" or the "Company") (CSE:FOMO), a North American mineral acquisition and exploration company, is pleased to announce that it has formally submitted its Application for Autorisation de Travaux d'exploration à Impacts (ATI) to the Ministère des Ressources naturelles et des Forets (MERN), marking an important step in advancing the Company's planned fully funded 5,000 metre drill program at its flagship N2 Gold Project ("N2") in Quebec, an advanced gold project with a global historic resource of 877,000 ounces: 18.2 Mt grading 1.48 g/t Au (~810,000 oz Au) across four zones (A, East, RJ-East, and Central) 2,3 and 243 Kt grading 7.82 g/t Au (~67,000 oz Au) across the RJ zone 2,4. Prior to filing, Formation Metals has held discussions with all necessary parties, including local municipalities, the Regional Government of Eeyou Istchee James Bay, and the Anishnabe Lac Simon community. |
accessnewswire.com |
2025-05-16 06:00:00 |
Czytaj oryginał (ang.) |
| ATI: Poised For Robust Growth As Well As Tariff Challenges |
Shares of ATI Inc. have surged due to reduced labor uncertainty and strong earnings, with a one-year price target 21.1% higher, rated as a Buy. ATI specializes in aerospace and defense materials, with robust growth prospects, a diversified supply chain, and a significant backlog of $3.9 billion. Despite competitive markets and tariff risks, ATI's strong Q1 results, share buybacks, and projected double-digit earnings growth make it a good investment candidate. |
seekingalpha.com |
2025-05-10 05:52:07 |
Czytaj oryginał (ang.) |
| ATI Inc.: Takes Off After Q1 Beat, Yet Still Undervalued And Poised To Climb Further |
ATI's Q1 2025 results showed strong growth, with a 9.7% YoY increase in revenue to $1.14 billion, driven by double-digit sales in defense and jet engines. Continued strength in the A&D end market and backlogs should drive consolidated top line growth in 2025. Focus on operational efficiency and U.S.-based production footprint expected to support future margin growth. |
seekingalpha.com |
2025-05-08 07:21:03 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Is Up 25.39% in One Week: What You Should Know |
Does Allegheny Technologies (ATI) have what it takes to be a top stock pick for momentum investors? Let's find out. |
zacks.com |
2025-05-07 17:00:39 |
Czytaj oryginał (ang.) |
| Is ATI Inc. (ATI) Stock Outpacing Its Basic Materials Peers This Year? |
Here is how Allegheny Technologies (ATI) and Brenntag AG (BNTGY) have performed compared to their sector so far this year. |
zacks.com |
2025-05-07 14:45:53 |
Czytaj oryginał (ang.) |
| ATI's Earnings and Revenues Surpass Estimates in Q1, Rise Y/Y |
ATI sees strong year-over-year sales growth in aerospace and defense in Q1. |
zacks.com |
2025-05-07 13:51:31 |
Czytaj oryginał (ang.) |
| ATI Stock Earns IBD Stock Rating Upgrade |
On Friday, ATI got an upgrade for its IBD SmartSelect Composite Rating from 80 to 97. |
investors.com |
2025-05-02 18:17:00 |
Czytaj oryginał (ang.) |
| ATI's Aerospace and Defense Leadership Recognized with GICS Code Update |
DALLAS , May 1, 2025 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announces that effective May 1, 2025, its Global Industry Classification Standard (GICS) code has been reclassified to Aerospace and Defense, providing further recognition of the Company's transformation into a world-class A&D supplier. Previously, ATI was categorized as Metals and Mining under the standardized industry classification system administered by S&P Dow Jones Indices and MSCI. |
prnewswire.com |
2025-05-01 20:30:00 |
Czytaj oryginał (ang.) |
| ATI Inc. (ATI) Q1 2025 Earnings Call Transcript |
ATI Inc. (NYSE:ATI ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants David Weston - Vice President, Investor Relations Kim Fields - President and CEO Don Newman - Executive Vice President and CFO Conference Call Participants Andre Madrid - BTIG Richard Safran - Seaport Research Partners Scott Deuschle - Deutsche Bank Seth Seifman - JPMorgan Phil Gibbs - Keybanc Capital Josh Korn - Barclays Gautam Khanna - TD Cowen Timna Tanners - Wolfe Research Josh Sullivan - The Benchmark Company Operator Hello and welcome everyone to the ATI First Quarter 2025 Earnings Call. My name is Becky and I'll be your operator today. |
seekingalpha.com |
2025-05-01 18:45:45 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Reports Q1 Earnings: What Key Metrics Have to Say |
The headline numbers for Allegheny Technologies (ATI) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-05-01 14:35:56 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Q1 Earnings and Revenues Beat Estimates |
Allegheny Technologies (ATI) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.48 per share a year ago. |
zacks.com |
2025-05-01 13:40:41 |
Czytaj oryginał (ang.) |
| Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia |
A review of recent findings suggests that Appili's biodefense vaccine, ATI-1701, may have a role in preventing tularemia outbreaks A review of recent findings suggests that Appili's biodefense vaccine, ATI-1701, may have a role in preventing tularemia outbreaks |
globenewswire.com |
2025-05-01 11:34:00 |
Czytaj oryginał (ang.) |
| ATI Announces First Quarter 2025 Results |
Strong year-over-year sales growth driven by aerospace & defense Aerospace and defense sales of $754 million, representing 66% of Q1 2025 sales Agreement with USW for Specialty Rolled Products employees ratified First Quarter 2025 GAAP Financial Results Sales of $1.14 billion, up 10% year-over-year, driven by a 23% aerospace & defense increase Net income attributable to ATI of $97 million, up 47% year-over-year Earnings per share of $0.67 compared to $0.46 per share in the first quarter 2024 First Quarter 2025 Non-GAAP Financial Information* Adjusted net income attributable to ATI* of $104 million, up 53% year-over-year Adjusted earnings per share* of $0.72, compared to $0.48 per share in the first quarter 2024 Adjusted EBITDA* of $195 million, an increase of 29% year-over-year Adjusted EBITDA* as a percentage of sales of 17.0%, compared to 14.5% in the first quarter 2024 Guidance The Company is providing second quarter and updated full year 2025 guidance in the table below, which assumes share repurchases of approximately $250 million in the second quarter. Guidance Q2 2025 Full Year 2025 Adjusted EBITDA** $195M - $205M $800M - $840M Adjusted Earnings Per Share** $0.67 - $0.73 $2.87 - $3.09 Adjusted Free Cash Flow** $240M - $360M Capital expenditures $260M - $280M * Reconciliations of the reported information under accounting principles generally accepted in the United States (GAAP) to non-GAAP financial measures are included in accompanying financial tables. |
prnewswire.com |
2025-05-01 11:30:00 |
Czytaj oryginał (ang.) |
| Unveiling Allegheny Technologies (ATI) Q1 Outlook: Wall Street Estimates for Key Metrics |
Besides Wall Street's top -and-bottom-line estimates for Allegheny Technologies (ATI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025. |
zacks.com |
2025-04-28 14:21:20 |
Czytaj oryginał (ang.) |
| Humata Health Powers First Touchless Prior Authorization – From Order to Approval – with Allegheny Health Network |
WINTER PARK, Fla.--(BUSINESS WIRE)--Humata Health announced that Allegheny Health Network is the first health system to implement truly touchless medical prior authorization. |
businesswire.com |
2025-04-28 13:00:00 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Outperforms Broader Market: What You Need to Know |
Allegheny Technologies (ATI) reachead $53.09 at the closing of the latest trading day, reflecting a +1.22% change compared to its last close. |
zacks.com |
2025-04-25 23:21:24 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Earnings Expected to Grow: Should You Buy? |
Allegheny Technologies (ATI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-04-24 15:07:52 |
Czytaj oryginał (ang.) |
| ATI Employees Ratify New Six-Year Agreement |
DALLAS , April 23, 2025 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced its employees have ratified a new six-year labor agreement with the United Steelworkers (USW). "We are pleased to have reached agreement with the USW for our Specialty Rolled Products employees at our Western Pennsylvania and Lockport, New York, facilities," said Kimberly A. |
prnewswire.com |
2025-04-23 12:00:00 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Sees a More Significant Dip Than Broader Market: Some Facts to Know |
In the latest trading session, Allegheny Technologies (ATI) closed at $47.23, marking a -0.84% move from the previous day. |
zacks.com |
2025-04-15 23:20:29 |
Czytaj oryginał (ang.) |
| Why Allegheny Technologies (ATI) Dipped More Than Broader Market Today |
In the most recent trading session, Allegheny Technologies (ATI) closed at $42.53, indicating a -1.09% shift from the previous trading day. |
zacks.com |
2025-04-07 23:20:43 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Rises Higher Than Market: Key Facts |
Allegheny Technologies (ATI) closed the most recent trading day at $56.11, moving +1.96% from the previous trading session. |
zacks.com |
2025-01-03 21:36:28 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 30th |
ATI, GPK and MTW have been added to the Zacks Rank #24 (Strong Sell) List on December 30, 2024. |
zacks.com |
2024-12-30 09:05:50 |
Czytaj oryginał (ang.) |
| Here's Why Allegheny Technologies (ATI) Fell More Than Broader Market |
Allegheny Technologies (ATI) closed the most recent trading day at $55.45, moving -1.23% from the previous trading session. |
zacks.com |
2024-12-27 21:20:24 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Increases Despite Market Slip: Here's What You Need to Know |
Allegheny Technologies (ATI) concluded the recent trading session at $54.23, signifying a +0.04% move from its prior day's close. |
zacks.com |
2024-12-19 21:06:30 |
Czytaj oryginał (ang.) |
| Applied Optoelectronics Filed a Patent Infringement Lawsuit Against Accelight Technologies, Inc. (ATI) |
SUGAR LAND, Texas, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (“AOI”) (Nasdaq: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, today announced that it has filed a complaint for patent infringement against Accelight Technologies, Inc. (ATI) in the U.S. District Court for the Northern District of California, Case No.: 3:24-cv-09041. |
globenewswire.com |
2024-12-17 18:10:00 |
Czytaj oryginał (ang.) |
| ATI Physical Therapy Announces Commencement of Tender Offer to Purchase Up to 1,650,000 Shares of its Class A Common Stock at a Purchase Price of $2.85 per Share |
BOLINGBROOK, Ill. , Dec. 17, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (OTCMKTS: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, announced today that it is commencing a tender offer to purchase for cash up to 1,650,000 shares of its Class A common stock (the "Shares") at a purchase price of $2.85 per Share. |
prnewswire.com |
2024-12-17 10:37:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 4th |
ATI, ARLP and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 4, 2024. |
zacks.com |
2024-12-04 06:35:21 |
Czytaj oryginał (ang.) |
| ATI Physical Therapy Receives Delisting Notice From the New York Stock Exchange |
BOLINGBROOK, Ill. , Dec. 3, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today announced that it received notification from the New York Stock Exchange ("NYSE") indicating that the Company's Class A common stock will be delisted, and trading of its Class A common stock on the NYSE was suspended, after market close on December 3, 2024. |
prnewswire.com |
2024-12-03 18:55:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 2nd |
ATI, ATS and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2024. |
zacks.com |
2024-12-02 07:31:12 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 22nd |
ATI, AKBA and ALTG have been added to the Zacks Rank #5 (Strong Sell) List on November 22, 2024. |
zacks.com |
2024-11-22 06:56:19 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 18th |
ATI, BALY and KOF have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2024. |
zacks.com |
2024-11-18 07:05:18 |
Czytaj oryginał (ang.) |
| Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 |
Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal models after one year Alignment with U.S. Food and Drug Administration on development requirements for ATI-1801 NDA Submission HALIFAX, Nova Scotia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the second quarter of its fiscal year 2025, which ended on September 30, 2024. All figures are stated in Canadian dollars unless otherwise stated. |
globenewswire.com |
2024-11-14 09:15:00 |
Czytaj oryginał (ang.) |
| For 5th Consecutive Year, ATI Physical Therapy Achieves 'Exceptional' Rating In Patient Quality from the Center For Medicare and Medicaid Services (MIPS) |
The Achievement Continues the Company's Streak in Earning the Rating Annually Since the Program Debuted in 2019 BOLINGBROOK, Ill. , Nov. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") today has again earned the "Exceptional" rating from the Center for Medicare and Medicaid Services' (CMS) Merit-Based Incentive Payment System (MIPS) for quality patient care. |
prnewswire.com |
2024-11-13 12:57:00 |
Czytaj oryginał (ang.) |
| ATI announces sale of precision rolled strip operations to Ulbrich |
Sharpens focus on strategic aerospace and defense markets, streamlines operations DALLAS , Nov. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced it completed the sale of its precision rolled strip operations in New Bedford, Massachusetts and Remscheid, Germany to Ulbrich Stainless Steels and Special Metals, Inc. (Ulbrich). "With this divestiture, ATI sharpens its focus on providing our aerospace and defense customers with the titanium, nickel, and alloyed products that are rolled, melted and/or finished throughout Specialty Rolled Products facilities," said Kimberly A. |
prnewswire.com |
2024-11-06 18:45:00 |
Czytaj oryginał (ang.) |
| ATI Physical Therapy Reports Third Quarter 2024 Results |
BOLINGBROOK, Ill. , Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today reported financial results for the third quarter ended September 30, 2024. |
prnewswire.com |
2024-11-04 18:05:00 |
Czytaj oryginał (ang.) |
| Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission |
Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the November 6, 2024 shareholders meeting HALIFAX, Nova Scotia, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that the U.S. Food and Drug Administration (“FDA”) has provided positive feedback regarding the development strategy for ATI-1801, and agreed on the necessary registration package to support a New Drug Application (“NDA”). ATI-1801, a novel topical formulation of paromomycin (15% w/w), is under advanced clinical development for treating cutaneous leishmaniasis, a disfiguring skin infection affecting hundreds of thousands globally. |
globenewswire.com |
2024-10-31 09:15:00 |
Czytaj oryginał (ang.) |
| ATI's Earnings Miss Estimates in Q3, Revenues Increase Y/Y |
ATI saw higher year-over-year sales in aerospace and defense in the third quarter. |
zacks.com |
2024-10-30 10:10:21 |
Czytaj oryginał (ang.) |
| ATI Inc (ATI) Q3 2024 Earnings Call Transcript |
ATI Inc (NYSE:ATI ) Q3 2024 Results Conference Call October 29, 2024 8:30 AM ET Company Participants David Weston - Vice President of Investor Relations Kim Fields - President, CEO & Director Don Newman - Executive VP of Finance & CFO Conference Call Participants Richard Safran - Seaport Research Partners Andre Madrid - BTIG David Strauss - Barclays Phil Gibbs - KeyBanc Capital Markets Timna Tanners - Wolfe Research Seth Seifman - JPMorgan Scott Deuschle - Deutsche Bank Operator Hello, everyone, and welcome to ATI's Third Quarter 2024 Earnings Call. My name is Lydia, and I will be your operator today. |
seekingalpha.com |
2024-10-29 14:09:15 |
Czytaj oryginał (ang.) |
| Allegheny Technologies (ATI) Q3 Earnings and Revenues Lag Estimates |
Allegheny Technologies (ATI) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.55 per share a year ago. |
zacks.com |
2024-10-29 11:46:08 |
Czytaj oryginał (ang.) |
| ATI Announces Third Quarter 2024 Results |
Ninth consecutive quarter with sales in excess of $1 billion Q3 2024 sales of $1.05 billion Q3 2024 net income attributable to ATI of $82.7 million, or $0.57 per share Aerospace & defense represent 62% of Q3 2024 sales Full year 2024 guidance updated Non-GAAP Information* Q3 adjusted net income attributable to ATI of $85.9 million, or $0.60 per share Q3 2024 ATI adjusted EBITDA of $185.7 million, or 17.7% of sales, up 100 basis points sequentially DALLAS , Oct. 29, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) reported third quarter 2024 results, with sales of $1.05 billion and net income attributable to ATI of $82.7 million, or $0.57 per share. Sequential Y-O-Y ($ in millions except per share amounts) Q3 2024 Q2 2024 Change Q3 2023 Change Sales $1,051.2 $1,095.3 (4) % $1,025.6 2 % Net income attributable to ATI $82.7 $81.9 1 % $90.2 (8) % Earnings per share $0.57 $0.58 (2) % $0.62 (8) % Non-GAAP information* Adjusted net income attributable to ATI* $85.9 $86.0 — % $94.2 (9) % Adjusted earnings per share* $0.60 $0.60 — % $0.64 (6) % ATI adjusted EBITDA* $185.7 $182.6 2 % $162.6 14 % * Detailed reconciliations of the reported information under accounting principles generally accepted in the United States (U.S. GAAP) to adjusted non-GAAP figures are included in accompanying financial tables. |
prnewswire.com |
2024-10-29 09:30:00 |
Czytaj oryginał (ang.) |